Titan Pharmaceuticals Inc (TTNP) — Cash Flow Reinvestment Rate
Titan Pharmaceuticals Inc (TTNP) has a Cash Flow Reinvestment Rate of 0.00x as of June 2016, reinvesting $9.00K (capex $9.00K ) from operating cash flow of $13.51 Million. Check Titan Pharmaceuticals Inc cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Titan Pharmaceuticals Inc Cash Flow Reinvestment Rate (1997–2016)
Historical reinvestment intensity for Titan Pharmaceuticals Inc across 3 annual periods. Explore debt repayment capacity of Titan Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Titan Pharmaceuticals Inc (1997–2016)
Year-by-year capital reinvestment analysis for Titan Pharmaceuticals Inc. For live market cap and broader valuation context, see Titan Pharmaceuticals Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.05x | $342.00K | $6.29 Million | $171.00K | ▼ -91.4% |
| 2012 | 0.63x | $1.15 Million | $1.83 Million | $1.15 Million | ▲ +4377.3% |
| 1997 | 0.01x | $100.00K | $7.10 Million | $100.00K | — |